XORTX Therapeutics (XRTX) Change in Cash (2020 - 2026)
XORTX Therapeutics' (XRTX) quarterly Change in Cash came in at -$614239.0 in Q1 2026, down 6.19% YoY from -$654798.6 in Q1 2025, and down 86.47% on a QoQ basis from -$329401.0 in Q4 2025.
XORTX Therapeutics (XRTX) Change in Cash (2020 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 7 years of Change in Cash data on file, last reported at -$614239.0 in Q1 2026.
- Quarterly Change in Cash fell 6.19% year-over-year to -$614239.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 million (up 15.22% YoY) and the FY2025 annual result came in at -$1.6 million, down 65.21% from the prior year.
- Change in Cash fell to -$614239.0 in Q1 2026, from -$329401.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $7.0 million in Q2 2022 to a low of -$8.4 million in Q4 2022.
- A 5-year average of -$787224.4 and a median of -$756968.0 in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash soared 1064.04% — and 2025, when it plunged 290.51%.
- Tracing XRTX's Change in Cash over 5 years: stood at -$8.4 million in 2022, then soared by 80.72% to -$1.6 million in 2023, then surged by 110.66% to $172902.0 in 2024, then sank by 290.51% to -$329401.0 in 2025, then tumbled by 86.47% to -$614239.0 in 2026.
- The last three Change in Cash figures came in at -$614239.0 (Q1 2026), -$329401.0 (Q4 2025), and $130438.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | -614,239.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -614,239.00 |
| Dec 31, 2025 | -329,401.00 |
| Sep 30, 2025 | 130,438.00 |
| Jun 30, 2025 | -831,761.00 |
| Mar 31, 2025 | -578,411.00 |
| Dec 31, 2024 | 172,902.00 |
| Sep 30, 2024 | -777,725.00 |
| Jun 30, 2024 | -756,968.00 |
| Mar 31, 2024 | 387,775.00 |
| Dec 31, 2023 | -1.62 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Mar 31, 2023 | -2.53 Mn |
| Dec 31, 2022 | -8.41 Mn |
| Sep 30, 2022 | 829,424.68 |
| Jun 30, 2022 | 7.02 Mn |
| Mar 31, 2022 | -2.64 Mn |
| Dec 31, 2021 | 10.99 Mn |
| Sep 30, 2021 | -119,881.93 |
| Jun 30, 2021 | -728,294.73 |